Quadrant Capital Group’s MediciNova MNOV Stock Holding History

Quadrant Capital Group’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-199	Closed	-$1K	–	2592
2021 Q2	$1K	Buy	+199	New	+$857	﹤0.01%	2294

Other funds holding MNOV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Quadrant Capital Group's MNOV Position: Q3 2021 in Review

Quadrant Capital Group sold out of MediciNova (MNOV) in Q3 2021, closing a stake of 199 shares — an estimated $1K sold.

Quadrant Capital Group first reported a position in MNOV in Q2 2021 and held it in 1 quarter. The position peaked at $1K in Q2 2021. 39 funds tracked by Wall St. Rank hold MNOV as of Q3 2021.

Quadrant Capital Group reported no remaining MediciNova position as of Q3 2021 after selling out during the quarter.
Quadrant Capital Group sold 199 MediciNova shares in Q3 2021, an estimated $1K.
Quadrant Capital Group first reported a position in MediciNova in Q2 2021 and held it in 1 quarter.
Quadrant Capital Group's MediciNova position peaked at $1K in Q2 2021.
39 funds tracked by Wall St. Rank held MediciNova as of Q3 2021.

Based on Quadrant Capital Group's 13F filing for Q3 2021, filed 12 Nov 2021.